In a 60-year-old man with a previously normal thyroid‑stimulating hormone (TSH) and low free thyroxine (T4) who stopped levothyroxine 100 µg daily one week ago, how does this affect the interpretation of his thyroid function tests?

Interpretation of Thyroid Function Tests After Recent Levothyroxine Discontinuation

The normal TSH with low T4 in this patient who stopped levothyroxine just one week ago most likely reflects residual suppression of the hypothalamic-pituitary-thyroid axis from exogenous thyroid hormone, and these results cannot be reliably interpreted to assess true thyroid function—you must wait at least 4-8 weeks after discontinuation before retesting.

Why Current Results Are Uninterpretable

The pharmacokinetics of levothyroxine make interpretation impossible at one week post-discontinuation:

• Levothyroxine has a half-life of approximately 7 days in euthyroid individuals, meaning significant circulating hormone remains at one week
• TSH suppression persists well beyond drug clearance because the pituitary-thyroid feedback axis requires time to reset after chronic exogenous hormone exposure
• The current pattern (normal TSH, low T4) represents a transitional state where exogenous T4 is declining but endogenous TSH production hasn't fully recovered

Proper Timing for Reassessment

Recheck thyroid function tests 4-8 weeks after levothyroxine discontinuation to allow:

• Complete clearance of exogenous levothyroxine 1
• Full recovery of the hypothalamic-pituitary-thyroid feedback mechanism
• Accurate assessment of the patient's true underlying thyroid function

This 4-8 week interval is the standard guideline-recommended timeframe for assessing thyroid function after any change in levothyroxine dosing or discontinuation 1.

What the Repeat Testing Will Reveal

At 4-8 weeks post-discontinuation, the results will clarify:

• If TSH remains normal with normal T4: The patient likely had unnecessary levothyroxine treatment (recent data shows 25.7% of adults ≥60 years can successfully discontinue levothyroxine 2)
• If TSH is elevated (>10 mIU/L) with low T4: Confirms overt hypothyroidism requiring treatment resumption
• If TSH is 4.5-10 mIU/L with low-normal T4: Represents subclinical hypothyroidism; treatment decisions should be individualized based on symptoms, though routine treatment is not recommended in this TSH range 3

Age-Specific Considerations for This 60-Year-Old

This patient's age is particularly relevant:

• TSH levels naturally increase with aging, and age-specific reference ranges may be more appropriate 4, 5
• Recent evidence shows that 63.6% of patients ≥60 years taking ≤50 mcg daily successfully discontinued levothyroxine 2
• At 100 mcg daily, this patient was on a moderate dose, making successful discontinuation less likely but still possible

Common Pitfalls to Avoid

Do not restart levothyroxine based on current results—the low T4 may simply reflect declining exogenous hormone without indicating true hypothyroidism. Premature treatment decisions based on transitional values lead to potentially unnecessary lifelong therapy.

Do not assume the original indication for levothyroxine was correct—many older adults are started on thyroid hormone for borderline TSH elevations that may not represent true disease, particularly given age-related TSH increases 5.

Clinical Action Plan

1. Reassure the patient that one week is too soon to assess thyroid status
2. Schedule repeat TSH and free T4 testing at 6-8 weeks post-discontinuation 1
3. Monitor for symptoms of hypothyroidism in the interim (fatigue, cold intolerance, constipation, weight gain)
4. Base treatment decisions on the 6-8 week results, not current values

The key principle: thyroid function testing during the transition period after levothyroxine discontinuation provides misleading information that cannot guide clinical decisions 1.